Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions
Assessing health impact of new antimicrobials could encourage further drug development

Assessing health impact of new antimicrobials could encourage further drug development

Credit: CC0 Public Domain

In a new report, researchers at the University of York have investigated the ways in which the value of new antimicrobial drugs could be assessed to help the NHS decide how much should be paid for them.

Commissioned by the Department of Health and Social Care and funded by the National Institute for Health Research (NIHR), the report aims to demonstrate how new drugs could be assessed based on their value to the NHS. Having such a system in place could help to incentivise manufacturers to produce more new antimicrobials.

Antimicrobial resistance (AMR) is a major global health concern, as infectious organisms become increasingly resistant to a range of antimicrobials. Pharmaceutical and biotechnology industries, however, are becoming reluctant to develop new drugs citing limited return on investment.

Pressing issue

Chief Medical Officer for England, Professor Dame Sally Davies, said:”It is no exaggeration to say antimicrobial resistance is among the most pressing issues we face globally.

“Finding ways to incentivise companies to develop new drugs is a vital component of our response to this escalating threat.

“Ensuring the NHS pays a fair price for new antimicrobials whilst conserving their use is essential and this report provides a platform to deliver this.”

International action

The Lord O’Neill Independent Review on AMR had previously recommended that countries should support international action through better national purchasing arrangements of antimicrobial drugs.

This new study informs the various ways that the NHS could pay for new antibiotic drugs, by making recommendations to the National Institute for Health and Care Excellence (NICE) on how to consider the appraisal of new antimicrobials.

Currently a conventional payment method is employed to fund new antimicrobials, which is based on how much of the drug the NHS uses. Some new antimicrobials are held in reserve for use only when existing products are ineffective due to resistance, but this strategy limits revenues to manufacturers reducing the attractiveness of developing new antimicrobials.

‘Delinked’ payment

The government is therefore considering a novel payment approach where the NHS pays for access to the drug; this means that payment is ‘delinked’ from the amount of the drug that is actually used. Establishing appropriate levels of payment, however, is complex.

Mark Sculpher, Professor of Health Economics at the University of York, said: “NICE plays an important role in using evidence to guide the NHS about the effectiveness and value for money of new pharmaceuticals.

“Given the priority associated with having new antimicrobial agents available with increasing drug resistance, any role for NICE in appraising these products needs to involve the most appropriate methods, evidence and process.

“Our latest report looks at how NICE could appraise the benefits of these new drugs so that the NHS can make informed decisions on sustainable funding.”

Evidence

The report recommends that, under a delinked payment system, NICE should use the available evidence to estimate the long-term impact on the health of the population based on the availability of a new antimicrobial.

This can provide more evidence to inform sustainable funding, which also takes into consideration the health benefits that could be produced if those resources were devoted to other NHS activities.

Professor Sculpher said: “Having new drugs available to treat infectious disease is a major priority internationally given the challenge of resistance. But the NHS has to be able to agree funding with the manufacturers of new products based on information about the benefits they are expected to confer on patients over many years.

“Estimating this impact is extremely difficult when the drugs become first available, as relevant evidence is limited. It is essential for the NHS to collect surveillance data on how drugs are used, their outcomes and changes in resistance.”

Public health

The report states that levels of funding by the NHS under ‘delinked’ arrangements cannot be set in stone permanently. Rather, they should be revisited as new evidence becomes available and estimates of population health impact are revised.

Meindert Boysen, Director of the NICE Centre for Health Technology Evaluation, said: “The report provides invaluable insights in to the issues and complexity of capturing the full public health value of new antimicrobials. We will continue to work with partners and stakeholders on how the recommendations could translate to a pragmatic value framework and payment model for new antimicrobials.”


Explore further:
FDA researchers report first evidence of ESBL producing E. Coli in US retail meat

Provided by:
University of York

Tagged with:

About author

Related Articles